In vertebrate retinas, specialized photoreceptors responsible for color vision (cone cells) arrange themselves in patterns ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

Satellites come in all shapes and sizes, but there aren't any that look quite like SPHEREx, an infrared observatory NASA ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since ...

Vertex, Inc. (NASDAQ:VERX – Free Report) – Stock analysts at DA Davidson decreased their FY2025 earnings estimates for shares of Vertex in a research report issued to clients and investors on ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other best pharma stocks to buy according to hedge funds. The US ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

National Hurricane Center announces changes to its products for the 2025 season. Experimental cone gets new symbol for counties under both hurricane watch and tropical storm warning. This year's ...

Investors with a lot of money to spend have taken a bearish stance on Vertex Pharmaceuticals VRTX. And retail traders should know. We noticed this today when the trades showed up on publicly ...

MIAMI - The iconic forecast cone used by the National Hurricane Center to predict the paths of tropical cyclones is set to undergo its annual update, with forecasts indicating that the product's ...